Post Covid Unit

HAVE YOU HAD COVID19 AND DO YOUR SYMPTOMS CONTINUE OR WORSEN AFTER SEVERAL MONTHS?
HAVE YOU RECOVERED, BUT NOT 100%?

IT COULD BE PERSISTENT COVID.

The World Health Organization (WHO) defines it as a Post Covid19 Condition, in patients who have had proven or possible Covid19 infection and that can NOT be explained by any other alternative diagnosis.

Different studies in Europe and North America establish a prevalence of this Condition around 20%.

The following symptoms have been described:

ABDOMINAL PAIN

ALTERATION OF THE MENSTRUAL PERIOD

ALTERATION OF SMELL AND TASTE

HEARING ALTERATIONS

ANXIETY

BLURRY VISION

CHEST PAIN

MENTAL FOG

COUGH

DEPRESSION

DIZZINESS

FATIGUE, TACHYCARDIA


INTERMITTENT FEVER

DIARRHOEA

CONSTIPATION

REFLUX

HEADACHE

MEMORY LOSS

JOINT PAIN

MUSCLE PAIN AND SPASMS

NEURALGIAS

LACK OF AIR, PALPITATION

POOR TOLERANCE TO EFFORT

INSOMNIA

In patients who have had severe Covid19 infection, the risk of developing dementia is increased by 10 years.

We have the means and the vocation to tackle this complex issue.

Difficulty concentrating

Sleep disturbances (insomnia)

General deterioration

Fatigue

Pain

The Centre Cugat Salut puts at your disposal a multidisciplinary experienced team that has been on the front line during the peak periods of the pandemic, and has also been part of hospital research teams.

We have the means and the vocation to tackle this complex issue.

THE APPROACH INCLUDES:

1

First medical visit

1

First medical visit

2

Study of probable respiratory sequelae that includes complete physical examination, assessment of oxygen saturation, electrocardiogram, transthoracic doppler echocardiogram. Orthostatic test.

2

Study of probable respiratory sequelae that includes complete physical examination, assessment of oxygen saturation, electrocardiogram, transthoracic doppler echocardiogram. Orthostatic test.

3

Clinical analysis including blood count, kidney and liver function, coagulation, and biomarkers that reflect inflammation.

3

Clinical analysis including blood count, kidney and liver function, coagulation, and biomarkers that reflect inflammation.

4

Respiratory functionality study such as Spirometry with Volumes and DLCO, Thoracic CT, Walking test

4

Respiratory functionality study such as Spirometry with Volumes and DLCO, Thoracic CT, Walking test

5

Analysis of biomarkers of neurological damage related to COVID, CT and brain MRI

5

Analysis of biomarkers of neurological damage related to COVID, CT and brain MRI

Based on the findings, a Centralized multidisciplinary approach will be followed that includes assessment by Neurology, Pulmonology, Psychiatry, Psychology, Speech Therapy, Internal Medicine.